Aspergillus brain abscess in a patient with acute myeloid leukaemia successfully treated with voriconazole

Clinical and Laboratory Haematology

Volumn 28, Issue 2, 2006, Pages 130-133

  Wandroo, F ^a,b   Stableforth, P ^a   Hasan, Y ^a  

^a SANDWELL AND WEST BIRMINGHAM HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

Author keywords

Acute leukaemia; Aspergillus brain abscess; Voriconazole

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; CYTARABINE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; ASPERGILLUS FUMIGATUS; BLOOD BRAIN BARRIER; BONE MARROW TRANSPLANTATION; BRAIN ABSCESS; BRAIN EDEMA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEATH; DETERIORATION; DRUG EFFICACY; DRUG PENETRATION; FACIAL NERVE PARALYSIS; FUNGICIDAL ACTIVITY; HUMAN; IMMUNE DEFICIENCY; LUNG ASPERGILLOSIS; LUNG LAVAGE; MALE; MORTALITY; NEUTROPENIA; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; THORAX RADIOGRAPHY;

ADULT; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BRAIN ABSCESS; CENTRAL NERVOUS SYSTEM FUNGAL INFECTIONS; HUMANS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MALE; PYRIMIDINES; TELENCEPHALON; TRIAZOLES;

EID: 33645303555     PISSN: 01419854     EISSN: 13652257     Source Type: Journal    
DOI: 10.1111/j.1365-2257.2006.00737.x     Document Type: Article

References (19)

1. Beal M.F. O'Carroll C.P. Kleinman G.M. Grossman R.I. 1982 Aspergillosis of the nervous system. Neurology 32 473 479.
2. Collette N. Van der Auwera P. Meunier F. Coune A. 1991 Tissue distribution and bioactivity of amphotericin administered in liposomes to cancer patients. Journal of Antimicrobial Chemotherapy 27 535 548.
3. Cosmo J.A. Dismukes W.E. 1994 Oral azole drugs as systemic antifungal therapy. New England Journal of Medicine 330 263 272.
4. Denning D.W. 1996 Therapeutic outcome in invasive aspergillosis. Clinical Infectious Disease 23 608 615.
5. Denning D.W. Ribaud P. Milpied N. Caillot D. Herbrecht R. Thiel E. Hass A. Ruhnke M. Lode H. 2002 Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clinical Infectious Disease 34 563 571
6. Francis P. Walsh T.J. 1992 Evolving role of flucytosine in immunocompromised patients: New insights into safety, pharmacokinetics and antifungal therapy. Clinical Infectious Disease 15 1003 1018.
7. Gripshover B.M. Ellner J.J. 2000 Chronic meningitis. In Principles and Practice of Infectious Diseases eds Mandel G.L. Bennett J.E. Dollin R. 5th edn pp. 997 1009. Churchill Livingstone Philadelphia
8. Hajdu R. Thompson R. Sundelof J.G. Pelak B.A. Bouffard F.A. Dropinski J.F. Kropp H. 1997 Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872). Antimicrobial Agents and Chemotherapy 41 2339 2344.
9. Herbrecht R. Denning D.W. Patterson T.F. Bennet J.E. Green R.E. Oestmann J.W. Kern W.V. Marr K.A. Ribaud P. Lortholary O. Sylvester R. Rubin R.H. Wingard R.J. Stark P. Durand C. Caillot D. Theil E. Chandrasekar P.H. Hodges M.R. Schlamm H.T. Troke P.F. Pauw B.D. 2002 Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. The New England Journal of Medicine 347 408 415.
10. Hoepelman A.I.M. Hodges M. Luster I. 2000 Cerebral aspergillosis and scedosporiosis: voriconazole, a new treatment option for children with life threatening cerebral fungal infection. (Abstract) Presented at the 18th European Society for Paediatric Infectious Diseases. Noordwijk
11. Jezequel S.G. Clark M. Evans K. Roffey S. Wastall P. Webster R. 1995 UK-109, 496, a noval, wide spectrum triazole derivative for the treatment of fungal infections: disposition in animals. (Abstract) 35th Interscience Conference on Antimicrobial Agents and Chemotherapy F77 126.
12. Kami M. Ogawa S. Kanda Y. 1999 Early diagnosis of central nervous system aspergillosis using polymerase chain reaction, latex agglutination test, and enzyme linked immunosorbant assay. British Journal of Haematology 106 536 537.
13. McGinnis M.R. 1983 Detection of fungi in cerebrospinal fluid. American Journal of Medicine 75 129 138.
14. Marr K.A. Boeckh M. Carter R.A. Kim H.W. Corey L. 2004 Combination antifungal therapy for invasive aspergillosis. Clinical Infectious Disease 39 797 802.
15. Patterson T.F. Kirkpatrick W.R. White M. 2000 Invasive aspergillosis. Disease spectrum, treatment practices and outcomes. 13 Aspergillus study group. Medicine 79 250 260.
16. Schwartz S. Milatovic D. Thiel E. 1997 Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia. British Journal of Haematology 97 663 665.
17. Schwartz S. Ruhnke M. Ribaud P. Corey L. Driscoll L. Cornely O. Schuler U. Lutsar I. Troke P. Eckhard T. 2005 Improved outcome in central nervous system aspergillosis with voriconazole treatment. Blood 106 2641 2645.
18. Tattevin P. Bruneel F. Lellouche F. de Broucker T. Chevret S. Wollf M. Regnier B. 2004 Successful treatment of brain aspergillosis with voriconazole. Clinical Microbiology and Infectious Diseases 10 922 950.
19. Verweij P.E. Brinkman K. Kremer H.P.H. Meis J.F.G.M. 1999 Aspergillus meningitis: diagnosis by nonculture based microbiological methods and management. Journal of Clinical Microbiology 37 1186 1189.